Beryl Drugs Share Price

BSE
BERLDRG •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Beryl Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
71.30% Gain from 52W Low
7.2
TTM PE Ratio
Below industry Median
56.6
Price to Book Ratio
Below industry Median
2.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.9

Beryl Drugs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Beryl Drugs Ltd Quarterly Revenue

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
4.73 Cr
3.63 Cr
3.24 Cr
4.88 Cr
2.51 Cr

Beryl Drugs Ltd Yearly Revenue

Mar 2018Mar 2017
15.99 Cr
11.53 Cr

Beryl Drugs Ltd Quarterly Net Profit/Loss

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
0.88 Cr
0.1 Cr
0.09 Cr
0.03 Cr
-0.02 Cr

Beryl Drugs Ltd Yearly Net Profit/Loss

Mar 2018Mar 2017
0.99 Cr
-0.41 Cr

Beryl Drugs Ltd shareholding Pattern

Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%

Beryl Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
38.40
10Day EMA
37.60
12Day EMA
37.40
20Day EMA
36.70
26Day EMA
36.50
50Day EMA
36.20
100Day EMA
35.60
200Day EMA
33.60
5Day SMA
38.80
10Day SMA
37.60
20Day SMA
35.60
30Day SMA
35.50
50Day SMA
36.50
100Day SMA
35.60
150Day SMA
34.90
200Day SMA
34.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
7946 Rs
9019 Rs
Week Rs
9735 Rs
12489 Rs
Month Rs
5562 Rs
9181 Rs
Resistance & Support
38.99
Pivot
Resistance
First Resistance
40.78
Second Resistance
43.75
Third Resistance
45.54
Support
First Support
36.02
Second support
34.23
Third Support
31.26
Relative Strength Index
55.70
Money Flow Index
85.11
MACD
0.88
MACD Signal
0.36
Average True Range
3.20
Average Directional Index
30.63
Rate of Change (21)
17.06
Rate of Change (125)
10.27

Beryl Drugs Ltd Company background

Founded in: 1993
Managing director: Sanjay Sethi
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplicillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Read More

Beryl Drugs Ltd FAQs

You can easily buy Beryl Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -